Global Retirement Partners LLC Raises Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Global Retirement Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 135.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,744 shares of the exchange traded fund’s stock after buying an additional 3,301 shares during the quarter. Global Retirement Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $568,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. HBK Sorce Advisory LLC boosted its stake in SPDR S&P Biotech ETF by 2.6% in the first quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after acquiring an additional 113 shares in the last quarter. Intellectus Partners LLC boosted its stake in SPDR S&P Biotech ETF by 1.0% in the second quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after acquiring an additional 113 shares in the last quarter. Pacific Center for Financial Services boosted its stake in SPDR S&P Biotech ETF by 2.8% in the first quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock valued at $414,000 after acquiring an additional 118 shares in the last quarter. Kingsview Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 3.8% in the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after acquiring an additional 127 shares in the last quarter. Finally, Bourgeon Capital Management LLC boosted its stake in SPDR S&P Biotech ETF by 5.9% in the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock valued at $225,000 after acquiring an additional 135 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.5 %

NYSEARCA:XBI opened at $99.83 on Monday. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm has a fifty day simple moving average of $99.08 and a 200-day simple moving average of $94.37. The company has a market capitalization of $7.61 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.